Olof F. Bengtsson
BioPharmaceuticals R&D
Goeteborg, O, Sweden
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Dapagliflozin and Days of Full Health Lost in the DAPA-HF Trial.
Journal: Journal of the American College of Cardiology
Published: March 13, 2024
Use of Win Statistics to Analyze Outcomes in the DAPA-HF and DELIVER Trials.
Journal: NEJM evidence
Published: February 06, 2024
Heart Failure, Investigator-Reported Sleep Apnea and Dapagliflozin: A Patient-Level Pooled Meta-Analysis of DAPA-HF and DELIVER.
Journal: Journal of cardiac failure
Published: June 08, 2023
Effect of Dapagliflozin on Total Heart Failure Events in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER Trial.
Journal: JAMA cardiology
Published: April 26, 2023
Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HF.
Journal: Circulation
Published: April 11, 2023
Dapagliflozin and Physical and Social Activity Limitations in Heart Failure With Reduced Ejection Fraction.
Journal: JACC. Heart failure
Published: January 03, 2023
Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection Fraction.
Journal: Journal of the American College of Cardiology
Published: September 27, 2022
Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF.
Journal: Circulation
Published: August 16, 2022
Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial.
Journal: The lancet. Diabetes & endocrinology
Published: August 01, 2022
Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER.
Journal: Nature medicine
Published: July 08, 2022
Last Updated: 09/26/2026